Endotherapy Devices Market Report 2026

Endotherapy Devices Market Overview

• Endotherapy Devices market size has reached to $4.87 billion in 2025 • Expected to grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Addressing The Global Obesity Epidemic Through The Role Of Endotherapy Devices In Weight Management • Market Trend: Advancements In Endotherapy Device Enhanced Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Endotherapy Devices Market?

Endotherapy devices are medical devices used in endoscopic procedures for the diagnosis, treatment, and management of various disorders such as gastrointestinal, colonoscopy, laparoscopy, anoscopy, arthroscopy, bronchoscopy, and others. These devices are designed to be used with an endoscope, a flexible tube with a light and camera attached that allows physicians to view the inside for better inspection of internal organs. The main types of endotherapy devices are gastrointestinal devices and accessories, endoscopic retrograde cholangiopancreatography devices and accessories, and other endotherapy devices. Gastrointestinal devices and accessories are medical devices used to diagnose and treat gastrointestinal (GI) disorders and are used for a range of procedures such as endoscopic examinations to visualize and access the inside of the GI tract such as the esophagus, stomach, duodenum, and colon and for surgical interventions to deliver therapies directly to the affected areas. Major applications are bronchoscopy, arthroscopy, laparoscopy, urology endoscopy, neuro-endoscopy, gastrointestinal endoscopy, and others by hospitals, ambulatory surgical centers, and other end-users.

What Is The Endotherapy Devices Market Growth Forecast?

The endotherapy devices market size is expected to see strong growth in the next few years. It will grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing investments in advanced endoscopy platforms, rising adoption of therapeutic endoscopic interventions, expansion of precision-guided endotherapy, growing demand for faster recovery procedures, increasing integration of ai-assisted endoscopy. Major trends in the forecast period include increasing adoption of advanced endoscopic treatment devices, rising use of minimally invasive endotherapy procedures, growing integration of electrosurgical and ablation technologies, expansion of therapeutic endoscopy applications, enhanced focus on procedure precision and safety.

What Is The Driver Of The Endotherapy Devices Market?

The increasing prevalence of obesity is expected to propel the growth of the endotherapy devices market going forward. Obesity is a medical condition characterized by the excessive accumulation of body fat to the extent that it may have adverse effects on health. Endotherapy devices can play a significant role in the management of obesity by assisting weight loss, reducing appetite, enhancing the quality of life, minimally invasive treatment, and providing temporary interventions. For instance, in March 2022, according to World Obesity, a US-based membership organization representing national and regional associations dedicated to the study and management of obesity, the number of obese people is expected to rise to 892 million in 2025 and then to 1,025 million in 2030. Therefore, the increasing prevalence of obesity is driving the growth of the endotherapy devices industry.

Key Players In The Global Endotherapy Devices Market

Major companies operating in the endotherapy devices market are Olympus Corporation, Boston Scientific Corporation, Medtronic plc, CONMED Corporation, Fujifilm Holdings Corporation, Karl Storz SE & Co. KG, Cook Medical Incorporated, Taewoong Medical Co. Ltd., Micro-Tech (Nanjing) Co. Ltd., B. Braun Melsungen AG, Pentax Medical, Nipro Corporation, Richard Wolf GmbH, Cogentix Medical Inc., Endogastric Solutions Inc., Gyrus ACMI, Cantel Medical Corp., Smith & Nephew plc, Stryker Corporation, HOYA Corporation, Steris Corporation

Global Endotherapy Devices Market Trends and Insights

Major companies operating in the endotherapy devices market are developing advanced solutions, such as red dichromatic imaging (RDI), to enhance the visualization of blood vessels and bleeding points during endoscopic procedures. Red dichromatic imaging in endotherapy devices enhances the visualization of blood vessels and lesions by using two distinct wavelengths of light, improving diagnostic accuracy during procedures. For Instance, in October 2023, Olympus Corporation, a Japan-based medical technology company, launched EVIS X1, an endoscopy system. EVIS X1 is a state-of-the-art endoscopy system that incorporates advanced imaging technologies and artificial intelligence to enhance visualization and diagnostic capabilities. The EVIS X1 endoscopy system incorporates advanced imaging technologies to enhance diagnostic capabilities. Its texture and color enhancement imaging (TXI) improves lesion and polyp visibility by enhancing color and texture. Red dichromatic imaging (RDI) focuses on deep blood vessels and bleeding points, while brightness adjustment imaging with maintenance of contrast (BAI-MAC) balances brightness levels across the image.

What Are Latest Mergers And Acquisitions In The Endotherapy Devices Market?

In January 2024, Olympus Corporation (Olympus), a Japan-based medical technology company, acquired Taewoong Medical Co. Ltd. for an undisclosed amount. This acquisition of Taewoong Medical enables Olympus to enhance patient outcomes by offering a broader array of clinically differentiated technologies, ultimately raising the standard of care in gastrointestinal treatments. Taewoong Medical Co. Ltd. is a South Korea-based manufacturer of medical devices such as gastrointestinal (GI) metallic stents.

What Defines the Endotherapy Devices Market?

The endotherapy devices market consists of sales of devices such as mechanically enhanced colonoscopies, endoscopic hemostasis, tissue sampling devices, metallic stents, dilation balloons, foreign body retrieval devices, electrosurgical needs, and UCR insufflators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Endotherapy Devices Market Report 2026?

The endotherapy devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the endotherapy devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.